
### [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759)
**Label:** b-cell non-Hodgkin lymphoma

**Subclasses:** [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive b-cell non-Hodgkin lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large b-cell lymphoma), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent b-cell non-Hodgkin lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), 

**Corr. equiv. classes:** [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:300846](http://www.orpha.net/ORDO/Orphanet_300846), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [OMIM:610430](http://purl.obolibrary.org/obo/OMIM_610430), [OMIM:615545](http://purl.obolibrary.org/obo/OMIM_615545), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 31.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 31.50%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 31.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 30.59%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 30.05%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 25.24%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.91%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 24.00%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 23.00%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 22.74%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 20.51%
- Thing 20.50%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 20.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 20.15%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 18.11%


